APA (7th ed.) Citation

Wang, J., Mikse, O., Liao, R. G., Li, Y., Tan, L., Janne, P. A., . . . Hammerman, P. S. (2015). Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells. Oncogene, 34(17), 2167-2177. https://doi.org/10.1038/onc.2014.161

Chicago Style (17th ed.) Citation

Wang, J., O. Mikse, R G. Liao, Y. Li, L. Tan, P A. Janne, N S. Gray, K-k Wong, and P S. Hammerman. "Ligand-associated ERBB2/3 Activation Confers Acquired Resistance to FGFR Inhibition in FGFR3-dependent Cancer Cells." Oncogene 34, no. 17 (2015): 2167-2177. https://doi.org/10.1038/onc.2014.161.

MLA (9th ed.) Citation

Wang, J., et al. "Ligand-associated ERBB2/3 Activation Confers Acquired Resistance to FGFR Inhibition in FGFR3-dependent Cancer Cells." Oncogene, vol. 34, no. 17, 2015, pp. 2167-2177, https://doi.org/10.1038/onc.2014.161.